- Home
- LNTH vs FRHC Comparison
LNTH vs FRHC Comparison
Compare LNTH & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- FRHC
- Stock Information
- Founded
- LNTH 1956
- FRHC 1981
- Country
- LNTH United States
- FRHC Kazakhstan
- Employees
- LNTH N/A
- FRHC N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- FRHC Investment Bankers/Brokers/Service
- Sector
- LNTH Health Care
- FRHC Finance
- Exchange
- LNTH Nasdaq
- FRHC Nasdaq
- Market Cap
- LNTH 7.5B
- FRHC 8.1B
- IPO Year
- LNTH 2015
- FRHC N/A
- Fundamental
- Price
- LNTH $101.32
- FRHC $129.05
- Analyst Decision
- LNTH Strong Buy
- FRHC
- Analyst Count
- LNTH 6
- FRHC 0
- Target Price
- LNTH $129.83
- FRHC N/A
- AVG Volume (30 Days)
- LNTH 830.2K
- FRHC 70.9K
- Earning Date
- LNTH 05-01-2025
- FRHC 02-07-2025
- Dividend Yield
- LNTH N/A
- FRHC N/A
- EPS Growth
- LNTH N/A
- FRHC N/A
- EPS
- LNTH 4.36
- FRHC 5.36
- Revenue
- LNTH $1,533,910,000.00
- FRHC $1,578,152,000.00
- Revenue This Year
- LNTH $5.74
- FRHC N/A
- Revenue Next Year
- LNTH $12.27
- FRHC N/A
- P/E Ratio
- LNTH $23.24
- FRHC $24.09
- Revenue Growth
- LNTH 18.32
- FRHC 79.07
- 52 Week Low
- LNTH $61.47
- FRHC $64.00
- 52 Week High
- LNTH $126.89
- FRHC $164.83
- Technical
- Relative Strength Index (RSI)
- LNTH 55.37
- FRHC 48.94
- Support Level
- LNTH $91.65
- FRHC $124.99
- Resistance Level
- LNTH $104.00
- FRHC $130.05
- Average True Range (ATR)
- LNTH 5.54
- FRHC 7.32
- MACD
- LNTH 0.34
- FRHC 0.61
- Stochastic Oscillator
- LNTH 85.89
- FRHC 65.57
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.